BeOne Medicines Ltd. (HKG:6160)

BeOne Medicines Revenue

BeOne Medicines had revenue of $1.12B USD in the quarter ending March 31, 2025, with 48.64% growth. This brings the company's revenue in the last twelve months to $4.18B, up 51.16% year-over-year. In the year 2024, BeOne Medicines had annual revenue of $3.81B with 54.96% growth.

• Revenue (ttm): $4.18B
• Revenue Growth: +51.16%
• P/S Ratio: 7.78
• Revenue / Employee: $379.62K
• Employees: 11,000
• Market Cap: 252.86B HKD

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.81B	1.35B	54.96%
Dec 31, 2023	2.46B	1.04B	73.65%
Dec 31, 2022	1.42B	239.64M	20.37%
Dec 31, 2021	1.18B	867.41M	280.83%
Dec 31, 2020	308.87M	-119.34M	-27.87%